RNAimmune Receives Investigational NDA Clearance from U.S. FDA for RV-1770
18 Dec 2023 //
PR NEWSWIRE
FDA Approves Drug Product Filled with Berkshire Sterile’s Low Loss Fill Process
19 May 2023 //
CONTRACT PHARMA
RNAimmune mRNA Cancer Vaccine Program Accepted for Oral Presentation at AACR
07 Feb 2023 //
PR NEWSWIRE
RNAimmune Secures $27M Series A Round of Financing
29 Mar 2022 //
PRNEWSWIRE
Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.
13 Oct 2020 //
BIOSPACE